Impact of eptifibatide on early ischemic events in acute ischemic coronary syndromes: a review of the IMPACT II trial. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. [electronic resource]
Producer: 19970918Description: 21B-28B p. digitalISSN:- 0002-9149
- Clinical Trials, Phase III as Topic
- Drug Administration Schedule
- Eptifibatide
- Humans
- Myocardial Ischemia -- mortality
- Peptides -- therapeutic use
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Randomized Controlled Trials as Topic
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.